How to dispose of Technetium-99m (Tc99m) and Fluorine-18 Fluorodeoxyglucose (F18 FDG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Disposal of Tc-99m and F-18 FDG Radioactive Materials

Radioactive waste from Tc-99m and F-18 FDG should be stored for 10 half-lives (60 hours for Tc-99m and 18 hours for F-18) before disposal, after which the material should be surveyed to confirm activity is below exemption levels. 1

General Principles for Radioactive Waste Disposal

  • Radioactive waste from nuclear medicine procedures requires special handling based on the radionuclide's half-life and emission characteristics 1
  • Tc-99m has a half-life of 6.01 hours with gamma emissions and an exemption level of 0.354 MBq 1
  • F-18 has a shorter half-life of 1.83 hours with beta-positive emissions and an exemption level of 2.880 MBq 1
  • The short half-lives of these radionuclides make decay-in-storage the most practical disposal method 1

Specific Disposal Protocol

For Tc-99m:

  • Store waste material for 10 half-lives (approximately 60 hours) 1
  • After storage period, less than 0.1% of the original activity remains 1
  • Survey the material with appropriate radiation detection equipment to verify activity is below exemption level (0.354 MBq) 1
  • If below exemption level, the material can be disposed of as regular medical waste 1

For F-18 FDG:

  • Store waste material for 10 half-lives (approximately 18 hours) 1
  • After storage period, survey to confirm activity is below exemption level (2.880 MBq) 1
  • F-18's shorter half-life offers advantages for waste management and pathological processing of tissue specimens 1
  • The higher exemption level for F-18 (compared to Tc-99m) allows for slightly higher residual activity before regular disposal 1

Handling Considerations

  • All waste storage areas should be appropriately shielded, secured, and surveyed weekly 1
  • For surgical waste containing these radionuclides, superficial contamination must be excluded and exemption levels observed 1
  • Semi-conductor germanium detectors can be used for high-precision measurement of specimens to determine if exemption levels are exceeded 1
  • Pathologists can generally process tissue specimens the day after surgery, but should verify activity levels are below exemption thresholds 1

Environmental Impact

  • Technetium-99m dominates discharges to the environment from excreta of nuclear medicine patients, but its short half-life limits its environmental impact 2
  • Storing patient's urine after procedures with these short-lived isotopes appears to have minimal benefit 2
  • Radionuclides released into modern sewage systems typically result in doses to workers and the public well below public dose limits 2

Occupational Safety Considerations

  • Personnel handling these materials should use appropriate radiation protection measures including gloves, lab coats, and radiation badges 1
  • The mean annual Dose Equivalent for nuclear medicine personnel is typically 100-140 mrem (1-1.4 mSv), well below maximum permissible doses 1
  • Exposure is generally higher for personnel working with PET isotopes like F-18 compared to those working with Tc-99m 1
  • Skin exposure rate from a 50-mL source filled with 1 MBq is 0.56 mSv/h for F-18 and 0.16 mSv/h for Tc-99m 1

Following these guidelines ensures safe disposal of Tc-99m and F-18 FDG radioactive materials while minimizing radiation exposure to staff and environmental impact.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.